Pharma company Sandoz named in US price-fixing lawsuit
The Germany-based subsidiary of Swiss pharmaceutical giant Novartis is one of 20 companies in the United States targeted in a 44-state class action suit for breaching rules on fair competition.
This content was published on
1 minute
SDA-Keystone/ac
The names of the companies were revealed on SundayExternal link by Connecticut Attorney General William Tong. The lawsuit accuses the companies of inflating the prices of more than 100 different drugs.
“Sandoz’s name appears in a court case, which concerns virtually the entire pharmaceutical generics industry,” Novartis told the Swiss news agency AWP. According to the Basel-based parent company, the accusations are unfounded and will be contested vigorously.
The American prosecutor mentioned that “Teva, Sandoz, Mylan, Pfizer and 16 other generic producers” are accused of conspiring among themselves to set prices, allocate markets and distort offers of more than 100 generic products. In some cases, the price of some substances increased more than tenfold. In addition to Sandoz, a former vice president at the company, Armando Kellum, was named as an individual defendant in the case.
“We have hard evidence that shows the generic drug industry perpetrated a multi-billion-dollar fraud on the American people,” said Tong. “We have emails, text messages, telephone records, and former company insiders that we believe will prove a multi-year conspiracy to fix prices and divide market share for huge numbers of generic drugs.
University students in Switzerland join Gaza protest wave
This content was published on
Pro-Palestinian activists occupied university buildings in Lausanne, Geneva and Zurich on Tuesday, widening the protest movement in the Alpine nation.
TradeXBank to resume full operations after Sberbank Switzerland taken off sanctions list
This content was published on
TradeXBank, the former Swiss branch of Russia’s Sberbank, will be able to resume its dollar-denominated activities from the second half of this year.
Geneva decides not to remove controversial memorials
This content was published on
The city of Geneva has presented an action plan regarding a series of controversial local statues and monuments of historical figures linked to racism, colonialism or slavery.
University of Lausanne calls for end to pro-Palestine sit-in
This content was published on
The pro-Palestinian occupation continues at the University of Lausanne (UNIL). On Monday evening, a group of students refused to agree to the deadline set by the rectorate.
Ukraine peace conference should include Russia, says Chinese ambassador
This content was published on
China supports a peace conference on the Ukraine war that would see equal participation of all parties, says Chinese Ambassador to Russia Zhang Hanhui.
This content was published on
A majority of Swiss citizens have open attitudes towards various infertility treatments, including even egg donation, which is currently prohibited.
Reports of Swiss cyber fraud almost doubled in six months
This content was published on
The head of the new Federal Office for Cybersecurity (FOC), Florian Schütz, has presented a new strategy after just over four months in office.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.